Insider Stock Transactions

Date Name Title Type Shares Traded Price Range
12-06-11 friedli peter Director Disposition (Non Open Market) 500,000 4.87
08-15-11 jacoby philip r jr Officer Option Execute 2,500 0.40
06-07-11 mills c randal Officer Disposition (Non Open Market) 500 6.97
06-06-11 barnhill gregory hurd Director Buy 25,000 7.07
06-03-11 barnhill gregory hurd Director Buy 25,000 7.20
02-14-11 barnhill gregory hurd Director Acquisition (Non Open Market) 5,000 7.13
02-14-11 friedli peter Director Acquisition (Non Open Market) 10,000 7.13
02-14-11 gutzwiller felix Director Acquisition (Non Open Market) 7,000 7.13
02-14-11 moyes jay m Director Acquisition (Non Open Market) 3,000 7.13
02-07-11 potter stephen w Officer Statement of Ownership 0 n/a
05-28-10 jacoby philip r jr Officer Option Execute 1,250 0.40
05-27-10 barnhill gregory hurd Director Acquisition (Non Open Market) 5,000 6.46
05-27-10 gutzwiller felix Director Acquisition (Non Open Market) 3,500 6.46
05-27-10 moyes jay m Director Acquisition (Non Open Market) 3,000 6.46
08-05-09 mills c randal Officer Disposition (Non Open Market) 500 12.23
05-14-09 debrabandere lode Officer Sell 37,500 12.49
05-14-09 debrabandere lode Officer Option Execute 37,500 6.84
02-23-09 barnhill gregory hurd Director Acquisition (Non Open Market) 5,000 18.60
02-23-09 friedli peter Director Acquisition (Non Open Market) 10,000 18.60
02-23-09 gutzwiller felix Director Acquisition (Non Open Market) 3,500 18.60
Showing 1-20 of 69 transactions Page: 1 2 3 4  See Next 20

Stock transaction information provided by EDGAR Online. Osiris Therapeutics makes no representation or warranty with respect any of to the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

©2012 Osiris Therapeutics, Inc. • 7015 Albert Einstein Drive • Columbia, MD • 21046 • p(443) 545-1800 osiris@osiris.com Legal Notice